Página 3 - Melhores Cancro cerebral médicos - TOP-95 médicos

O Prof. Adjunto Nail Paksoy traz uma vasta experiência em oncologia do Instituto de Oncologia da Universidade de Istambul e do Hospital Medipol Bahçelievler.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Participar em mais de 8 ensaios clínicos internacionais para cancros avançados
• Publicar mais de 30 artigos de investigação sobre tratamentos oncológicos inovadores
• Especializar-se em terapias alvo e abordagens de oncologia de precisão

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

A Professora Gül Alco é especialista em rádio-oncologia na Universidade Medipol de Istambul, com mais de 20 anos de experiência.

• Especializar-se em rádio-oncologia para cancro cerebral
• Professora nas universidades Demiroglu Bilim e Medipol
• Graduada pela Faculdade de Medicina da Universidade de Istambul

A Dra. Inta Jaunalksne é especialista em viroterapia, uma das áreas mais recentes da imunologia, com mais de 30 anos de experiência.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna
• Focar em tratamentos imunológicos inovadores para câncer cerebral

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Dr. Salman traz uma vasta experiência em oncologia de instituições de prestígio, como o Memorial Sloan Kettering Cancer Center e o Moffitt Cancer Center.

• Mais de 15 anos de especialização em oncologia médica
• Especialista em terapias-alvo e imunoterapia
• Membro da diretoria da Sociedade Turca de Oncologia Médica
• Ativo em pesquisa clínica e tratamentos experimentais
• Tratar casos de cancro raros e complexos

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Especializado no tratamento de tumores cerebrais no Hospital Internacional Medicalpoint, com uma sólida base em oncologia pela Universidade Hacettepe.

• Experiente no tratamento de vários tipos de cancro, incluindo tumores cerebrais
• Formado na Universidade Hacettepe – um centro de oncologia de referência
• Membro da ESMO e da Associação Turca de Oncologia Médica

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Especialista em cirurgias endoscópicas e remoção de tumores cerebrais no Samsung Medical Center – um dos principais hospitais de neurocirurgia da Coreia do Sul.

• Tratar pacientes pediátricos e adultos
• Experiência em tumores cerebrais benignos e malignos
• Dominar técnicas de radiocirurgia

Pioneiro na investigação de síndromes neurológicas paraneoplásicas – O Dr. Graus definiu os seus critérios de diagnóstico. Trabalha no Hospital Quiron Barcelona.

• 39 anos de experiência em neuro-oncologia
• Especializado em gliomas e linfomas cerebrais primários
• Ex-Chefe de Neurologia do Hospital Clinic
• Fundador e ex-presidente da EANO
• Doutoramento Honoris Causa pela Universidade de Lyon

Especializado em radioterapia para câncer cerebral, o Dr. Michael Van Kampen oferece tratamento direcionado na Clínica Nordwest.

• Experiência focada em radioterapia para tumores cerebrais
• Trabalhar na Clínica Nordwest – um centro de oncologia de referência
• Personalizar os planos de tratamento para as necessidades de cada paciente

A Dra. Jablonski-Perec formou-se no mundialmente conceituado Sloan-Kettering Cancer Center em Nova Iorque e tornou-se chefe de oncologia no Hadassah Medical Center.

• Mais de 25 anos na liderança de departamentos de oncologia e centros de tratamento
• Professora de Oncologia na Universidade Hebraica – uma das melhores faculdades de medicina de Israel
• Chefe do Centro de Tratamento de Cancro da Mama desde 1998
• Membro de várias sociedades internacionais de oncologia
• Premiada com uma prestigiada bolsa de estudo da Hadassah Medical School